InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.
2005
514
LTM Revenue $138M
LTM EBITDA $26.1M
$133M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
InfuSystem has a last 12-month revenue of $138M and a last 12-month EBITDA of $26.1M.
In the most recent fiscal year, InfuSystem achieved revenue of $135M and an EBITDA of $19.3M.
InfuSystem expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See InfuSystem valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $126M | $135M | XXX | XXX | XXX |
Gross Profit | $62.6M | $63.1M | XXX | XXX | XXX |
Gross Margin | 50% | 47% | XXX | XXX | XXX |
EBITDA | $16.5M | $19.3M | XXX | XXX | XXX |
EBITDA Margin | 13% | 14% | XXX | XXX | XXX |
Net Profit | $18K | $0.9M | XXX | XXX | XXX |
Net Margin | 0% | 1% | XXX | XXX | XXX |
Net Debt | $33.0M | $28.9M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, InfuSystem's stock price is $5.
InfuSystem has current market cap of $105M, and EV of $133M.
See InfuSystem trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$133M | $105M | XXX | XXX | XXX | XXX | $0.14 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, InfuSystem has market cap of $105M and EV of $133M.
InfuSystem's trades at 1.0x LTM EV/Revenue multiple, and 5.1x LTM EBITDA.
Analysts estimate InfuSystem's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for InfuSystem and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $133M | XXX | XXX | XXX |
EV/Revenue | 1.0x | XXX | XXX | XXX |
EV/EBITDA | 6.9x | XXX | XXX | XXX |
P/E | 44.8x | XXX | XXX | XXX |
P/E/Growth | 0.6x | XXX | XXX | XXX |
EV/FCF | 50.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpInfuSystem's NTM/LTM revenue growth is 9%
InfuSystem's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, InfuSystem's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate InfuSystem's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for InfuSystem and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 7% | XXX | XXX | XXX | XXX |
EBITDA Margin | 14% | XXX | XXX | XXX | XXX |
EBITDA Growth | 17% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | 23% | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.3M | XXX | XXX | XXX | XXX |
Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 8% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 38% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
Opex to Revenue | 47% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Philips | XXX | XXX | XXX | XXX | XXX | XXX |
Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
Senseonics Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
InfuSystem acquired XXX companies to date.
Last acquisition by InfuSystem was XXXXXXXX, XXXXX XXXXX XXXXXX . InfuSystem acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was InfuSystem founded? | InfuSystem was founded in 2005. |
Where is InfuSystem headquartered? | InfuSystem is headquartered in United States of America. |
How many employees does InfuSystem have? | As of today, InfuSystem has 514 employees. |
Who is the CEO of InfuSystem? | InfuSystem's CEO is Mr. Richard DiIorio. |
Is InfuSystem publicy listed? | Yes, InfuSystem is a public company listed on ASE. |
What is the stock symbol of InfuSystem? | InfuSystem trades under INFU ticker. |
When did InfuSystem go public? | InfuSystem went public in 1992. |
Who are competitors of InfuSystem? | Similar companies to InfuSystem include e.g. Philips, Perspective Therapeutics, SmartVest, Myomo. |
What is the current market cap of InfuSystem? | InfuSystem's current market cap is $105M |
What is the current revenue of InfuSystem? | InfuSystem's last 12-month revenue is $138M. |
What is the current EBITDA of InfuSystem? | InfuSystem's last 12-month EBITDA is $26.1M. |
What is the current EV/Revenue multiple of InfuSystem? | Current revenue multiple of InfuSystem is 1.0x. |
What is the current EV/EBITDA multiple of InfuSystem? | Current EBITDA multiple of InfuSystem is 5.1x. |
What is the current revenue growth of InfuSystem? | InfuSystem revenue growth between 2023 and 2024 was 7%. |
Is InfuSystem profitable? | Yes, InfuSystem is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.